| Product Name | MF | CAS | Details |
|---|
| 4-[(Pyridin-4-ylmethyl)-amino]-benzoic acid | C13H12N2O2 | 5966-20-1 | Details |
| 4-Methyl-2-[3-[(1-methylethyl)amino]-1-phenylpropyl]phenol | C19H25NO | 480432-14-2 | Details |
| 1,6-Dihydro-6-methyl-7H-pyrrolo[2,3-c]pyridin-7-one | C8H8N2O | 116212-46-5 | Details |
| 3-Chloro-4-(phthalazin-1-yloxy)aniline | C14H10ClN3O | 1154654-56-4 | Details |
| 2,3,4-Trifluoro-6-iodoaniline | C6H3F3IN | 1526686-27-0 | Details |
| 2,5-Diiodopyridine | C5H3I2N | 116195-81-4 | Details |
| 3-Chloroquinoxaline-2-carboxylic acid | C9H5ClN2O2 | 20254-76-6 | Details |
| N-[(Quinolin-8-yl)methyl]methanesulfonamide | C11H12N2O2S | 1486517-97-8 | Details |
| Methyl 4-fluorothiophene-3-carboxylate | C6H5FO2S | 1784076-89-6 | Details |
| CHIR-98023 | C20H16Cl2N8O2 | 252916-76-0 | Details |
| PTH ELISA kit | Details |
| 5’-Deoxy-5’-iodo-5-methyluridine | C10H13IN2O5 | 1884334-62-6 | Details |
| 1-Iodo-4-[(trifluoromethyl)sulfanyl]benzene | C7H4F3IS | 372-15-6 | Details |
| Moluccanin | C20H18O8 | 116521-73-4 | Details |
| 5-Amino-2,4-dibromophenol | C6H5Br2NO | 367521-07-1 | Details |
| 2,3-Difluoro-4-methoxybenzoic acid | C8H6F2O3 | 329014-60-0 | Details |
| 2-chloro-6-(trifluoromethyl)imidazo[1,2-a]pyridine | C8H4ClF3N2 | 112601-16-8 | Details |
| 1-(Pyridin-4-yl)ethane-1,2-diol hydrochloride | C7H10ClNO2 | 1750-97-6 | Details |
| H-VGGNYNYLYRLFRKS-OH | Details |
| aza(3-(4-bromophenyl)-7-(2-methylpropyl)(6,7,8-trihydrocinnolin-5-ylidene))methoxymethane | C19H22BrN3O | 1024823-06-0 | Details |
| Boc-D-Lys(Cl-Z)-OH | C19H27ClN2O6 | 57096-11-4 | Details |
| 4-Fluoro-3-(hydroxymethyl)benzoic acid | C8H7FO3 | 816449-68-0 | Details |
| 2-Hydroxy-4-(methylthio)butyric acid calcium salt | C5H12CaO3S | 4857-44-7 | Details |
| S-Timolol maleate | C17H28N4O7S | 26921-17-5 | Details |
| Buspirone hydrochloride | C21H32ClN5O2 | 33386-08-2 | Details |
| SLCO3A1 Blocking Peptide | Details |
| H-KDLLEQKRAAVDTYC-NH2 | Details |
| 2,4-dichloro-5-methylbenzene-1-sulfonyl chloride | C7H5Cl3O2S | 28286-86-4 | Details |
| 3-Amino-N,N-dimethyl-4-(morpholin-4-yl)benzene-1-sulfonamide | C12H19N3O3S | 1018638-08-8 | Details |
| 2-Fluoro-4-(3-trifluoromethylphenyl)benzoic acid | C14H8F4O2 | 926222-59-5 | Details |
| [1-(4-Methanesulfonylphenyl)ethyl](methyl)amine hydrochloride | C10H16ClNO2S | 1093630-40-0 | Details |
| 1-(1-Methyl-1H-imidazol-2-yl)piperazine dihydrochloride | C8H15ClN4 | 1394041-47-4 | Details |
| 2-Amino-3-{[(3-methoxyphenyl)methyl]sulfanyl}propanoic acid | C11H15NO3S | 1030621-97-6 | Details |
| 1,1-Dioxo-2H,3H,5H-1λ?-thieno[2,3-c]pyrrole-2-carboxylic acid | C7H7NO4S | 2377032-57-8 | Details |
| 1-(2-Fluoro-3-methoxyphenyl)piperazine hydrochloride | C11H16ClFN2O | 2172605-22-8 | Details |
| CSFR antibody (Tyr809) | Details |
| 6-Methylthioguanosine-5’-triphosphate sodium salt - 10 mM aqueous solution | C11H18N5O13P3S | 70318-62-6 | Details |
| 5,6-Dichlorovanillic acid | C8H6Cl2O4 | 108544-97-4 | Details |
| H-GSMVVIPTYALHHDPK-OH | Details |
| H-PVDEALR^-OH | Details |
| 2,6-Diethyl-4-phenyl-1-propylpyridinium tetrafluoroborate | C18H24BF4N | 88292-57-3 | Details |
| FTSJD1 Blocking Peptide | Details |
| 3-(1,5-Dimethyl-1H-pyrazol-4-yl)-4,5-dihydro-1,2-oxazole-5-carboxylic acid | C9H11N3O3 | 1006496-70-3 | Details |
| 5S,12R,18R-Trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid | C20H30O5 | 552830-51-0 | Details |
| CMVpp65 - 97 (WDRHDEGAAQGDDDV) | Details |
| 1-Cyclopropyl-1H-1,3-benzodiazole-6-carboxylic acid | C11H10N2O2 | 1368588-55-9 | Details |
| 1-[(4-Chlorophenyl)sulfanyl]butan-2-one | C10H11ClOS | 51828-54-7 | Details |
| Cymiazole | C12H14N2S | 61676-87-7 | Details |
| Thiomorpholine-4-carbothioamide | C5H10N2S2 | 72662-56-7 | Details |
| 3-Methyl-5-(naphthalen-2-yl)-1H-1,2,4-triazole hydrobromide | C13H11N3·HBr | 1221723-88-1 | Details |
| Methyl 3-[(3-aminopyridin-2-yl)sulfanyl]propanoate | C9H12N2O2S | 111042-83-2 | Details |
| 2-Methyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-4-one | C10H11NOS | 96680-77-2 | Details |
| SLC12A2 Blocking Peptide | Details |
| XPB antibody | Details |
| CCNT1 antibody | Details |
| C8orf70 Blocking Peptide | Details |
| Methyl 1-ethyl-5-formyl-3-methyl-1H-pyrazole-4-carboxylate | C9H12N2O3 | 1823817-98-6 | Details |
| APC 366 | C22H28N6O4 | 158921-85-8 | Details |
| 3-[1-(Ethoxymethyl)-3,5-dimethyl-1H-pyrazol-4-yl]-2-methylpropanoic acid | C12H20N2O3 | 1909308-76-4 | Details |
| AURKB antibody | Details |
| Glycoprotein 2 antibody | Details |
| (S)-N-Fmoc-2-(3'-butenyl)glycine | C21H21NO4 | 851909-08-5 | Details |
| N-1,3-Benzodioxol-5-yl-1-(4-nitrobenzyl)-1H-imidazole-4-carboxamide | C18H14N4O5 | 1351788-43-6 | Details |
| tert-Butyl morpholine-3-carboxylate hydrochloride | C9H18ClNO3 | 1269446-54-9 | Details |
| S 32212 hydrochloride | C25H29ClN4O2 | 847871-78-7 | Details |
| CSTF3 antibody | Details |
| 1-(Aminomethyl)-3-hydroxycyclobutane-1-carboxylic acid hydrochloride | 2137723-29-4 | Details |
| H-IDSLLENDR^-OH | Details |
| 5-Chloro-2,3-difluoropyridine-4-carbaldehyde | C6H2ClF2NO | 1333319-52-0 | Details |
| 2-(Aminomethyl)-N-(2-hydroxyethyl)-N-methylbenzene-1-sulfonamide hydrochloride | C10H17ClN2O3S | 1355644-95-9 | Details |
| Boscialin | C13H22O3 | 129277-03-8 | Details |
| 7-Phenyl-1,4-thiazepane hydrochloride | C11H16ClNS | 2097937-23-8 | Details |
| 4-(Chloromethyl)-2-[4-fluoro-3-(trifluoromethyl)phenyl]-1,3-oxazole | C11H6ClF4NO | 1283294-73-4 | Details |
| 5-(3-Chlorophenyl)-4,5-dihydro-1,2-oxazole-3-carboxylic acid | C10H8ClNO3 | 1018052-82-8 | Details |
| 2-Amino-6-bromopyridin-4-ol | C5H5BrN2O | 1807033-71-1 | Details |
| 5-Nitro-1-phenyl-1H-1,3-benzodiazole-2-thiol | C13H9N3O2S | 733031-20-4 | Details |
| Ethyl 5-(bromomethyl)pyridine-2-carboxylate hydrobromide | C9H11Br2NO2 | 1864052-50-5 | Details |
| 2,4-Dichloro-8,8-dimethyl-5,6,7,8-tetrahydroquinazoline | C10H12Cl2N2 | 1538445-96-3 | Details |
| 5-Fluoro-4-methoxypyrimidine-2-carboxylic acid | C6H5FN2O3 | 1545825-63-5 | Details |
| 5-(5-Fluoro-1-methyl-1H-1,3-benzodiazol-2-yl)-2-methylaniline | C15H14FN3 | 1183150-96-0 | Details |
| H-SSKGR-OH | Details |
| Arntl2 Blocking Peptide | Details |
| (1,2-Dimethylpyrrolidin-3-yl)methanamine dihydrochloride | C7H17ClN2 | 1955494-57-1 | Details |
| 2-Methyl-1-{5H,6H,7H-pyrrolo[2,1-c][1,2,4]triazol-3-yl}propan-1-amine | C9H16N4 | 1094444-89-9 | Details |
| 5'-O-Isobutyryl-2',3'-O-isopropylidene-N4-triazolylcytidine | Details |
| 3-(1-Ethyl-3-methyl-1 H -pyrazol-4-yl)-4,5-dihydro-isoxazole-5-carboxylic acid | C10H13N3O3 | 907990-49-2 | Details |
| 6-Ethenyl-3-methyl-4-phenyl-2-pyridinecarboxylic acid methyl ester | C16H15NO2 | 64034-94-2 | Details |
| Sodium 2-[(diethylamino)methyl]benzene-1-sulfonate | C11H18NNaO3S | 1394040-54-0 | Details |
| 3-{1,4-Dioxaspiro[4.5]decan-8-yl}prop-2-ynoic acid | C11H14O4 | 2247102-20-9 | Details |
| OR8K3 antibody | Details |
| 3-Ethylpyrrolidine-2-carboxylic acid hydrochloride | C7H14ClNO2 | 104757-47-3 | Details |
| Influenza A Nucleoprotein ELISA Kit | Details |
| 4-Ethoxy-2,3-dihydro-1H-isoindole-1,3-dione | C10H9NO3 | 41709-84-6 | Details |
| 3-Cyclopropylpyridine-2-carboxylic acid hydrochloride | C9H10ClNO2 | 2375274-08-9 | Details |
| 4-Chloro-3-(2,3-dihydro-1H-indole-1-sulfonyl)benzoic acid | C15H12ClNO4S | 380342-93-8 | Details |
| H-GLNKIVRMY-OH | Details |
| 1-Methyl-1H-1,3-benzodiazol-6-ol | C8H8N2O | 50591-23-6 | Details |
| Human NGFb ELISA Kit | Details |
| 3-Methyl-2-(pyridine-4-amido)benzoic acid | C14H12N2O3 | 68279-85-6 | Details |
| PFDN6 antibody | Details |
| Product Total： Product Page： | ||||
| 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 | ||||